Updates from The Motley Fool

Latest updates on Alexion Pharmaceuticals, Inc. from Fool.com.


Stock Performance

ALXN vs. S&P 500 | 2 Year Performance
ALXN 1-Day Stock Chart
ALXN 5-Day Stock Chart
ALXN 1-Month Stock Chart
ALXN 3-Month Stock Chart
ALXN 6-Month Stock Chart
ALXN 1-Year Stock Chart
ALXN 2-Year Stock Chart
ALXN 5-Year Stock Chart
View Interactive ALXN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alexion Pharmaceuticals, Inc..
Current Price: $139.55
Prev Close: $142.53
Open: $141.88
Bid: $139.82
Ask: $139.99
Day's Range: $137.40 - $142.30
52wk Range: $124.16 - $208.88
Volume: 1,315,418
Avg Vol 1,638,104
Market Cap: $31.44B
P/E (ttm): 285.06
EPS (ttm): $0.67
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alexion Pharmaceuticals, Inc..
CAPS Rating 3 out of 5
 
306 Outperform
61 Underperform
CAPS All Stars
 
73 Outperform
11 Underperform

How do you think Alexion Pharmaceuticals, Inc. will perform against the market?



You pick for Alexion Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David Hallal, CEO

64% Approve

Based on 12 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alexion Pharmaceuticals, Inc..

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers